BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 17, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Washington roundup: Trustees add two years to life of Medicare Part A trust fund

June 3, 2013
By Mark McCarty

Deals roundup: Smith Group in early stage talks for sale of medical division

June 3, 2013

Agreements/contracts: Hamilton partners with Illumina for NGS prep

June 3, 2013

ASCO notebook: Researchers demonstrate cfDNA effectiveness as companion test

June 3, 2013

HIT roundup: New app gives quick access to oncology-specific journal articles

June 3, 2013

5 for Five: Device coverage from the pages of MDD

May 31, 2013
By Mark McCarty
The merry month of May is just about kaput, so let’s ask ourselves how entertaining the past five months of May have been. Entertaining, that is, if you’re a med tech geek or wonk, and it’s a cinch you’re one or both of those if you’re reading this. 2008 The May 5, 2008, edition of Medical Device Daily included a story by MDD’s Omar Ford describing the decision by the Centers for Medicare & Medicaid Services to cover the use of artificial hearts. The decision was a landmark for patients, but one...
Read More

Report from Israel: Israel looks set to begin to harness Bio Crowd power

May 31, 2013
By Jonathan Goldstein
The IATA Biomed Israel conference is planned in Tel Aviv for early next month. The organizing committee is expecting approximately 6,000 visitors, over 1,000 of whom are expected from outside Israel. The conference focuses on life science and device innovations of different stages, from Teva Pharmaceuticals (Petach Tikva), to technology startups with a name, limited IP, and no full-time employees. The environment is ripe for generating new ideas, and especially for local and international networking. Last year's 3,500 one-on-one networking meetings will likely be equaled in number this year, and based on the number of returning guests, there seems to be great promise in the Promised Land.
Read More

Washington roundup: CMS proposes expanded set of indications for dual pacing

May 31, 2013
By Mark McCarty

HIT roundup: Physz.com in plan to launch new mobile application for iPhone

May 31, 2013

Financings roundup: Invacare reports successfully amending credit agreement

May 31, 2013
Previous 1 2 … 3529 3530 3531 3532 3533 3534 3535 3536 3537 … 10247 10248 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 15, 2026.
  • Illustration of a glowing circle to represent circRNA

    ASGCT 2026: Circular RNA, the new beast in gene and cell therapy

    BioWorld
    Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
  • Test tubes, dropper and capsules

    Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal

    BioWorld
    In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
  • 3D illustration of adeno-associated viruses

    ASGCT 2026: Uncovering the mechanisms of AAV toxicity

    BioWorld
    Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
  • Amyloid plaques on nerve cell

    Roche secures CE mark for Alzheimer’s blood test

    BioWorld
    Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing